⌘K

Login Start Free

Home/Filings/4/0001610717-23-000319

4//SEC Filing

BLATT LAWRENCE 4

Accession 0001610717-23-000319

CIK 0001799448other

View on SEC.gov Company Profile

Filed

Oct 26, 8:00 PM ET

Accepted

Oct 27, 4:14 PM ET

Size

9.5 KB

Accession

0001610717-23-000319

Insider Transaction Report

Form 4

Period: 2023-10-25

Aligos Therapeutics, Inc.ALGS

DirectorPresident and CEO

Transactions

Award
Common Stock
2023-10-25$0.76/sh+610,277$461,858→ 1,847,575 total
Award
Warrants (Right to Buy)
2023-10-25$0.13/sh+305,138$38,142→ 305,138 total
Exercise: $0.76From: 2023-10-25Exp: 2030-10-25→ Common Stock (305,138 underlying)

Holdings

Common Stock
(indirect: See footnote)
113,423
Common Stock
(indirect: See footnote)
122,601
Common Stock
(indirect: See footnote)
18,517
Common Stock
(indirect: See footnote)
18,517

Footnotes (4)

[F1]Lawrence M. Blatt Living Trust dated 8/27/14.
[F2]PENSCO Trust Company LLC Custodian FBO Dr. Lawrence Blatt IRA.
[F3]Zachary David Blatt Irrevocable Trust dated 8/24/14.
[F4]Zoe Anne Blatt Irrevocable Trust dated 8/24/14.

Documents

1 file

4
form4.xmlPrimary

Issuer

Aligos Therapeutics, Inc.

CIK 0001799448

Entity typeother

Related Parties

1

filerCIK 0001242110

Filing Metadata

Form type: 4
Filed: Oct 26, 8:00 PM ET
Accepted: Oct 27, 4:14 PM ET
Size: 9.5 KB

View on SEC.gov